These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27049372)

  • 1. Pathogenesis and treatment of glomerulonephritis-an update.
    Couser WG
    J Bras Nefrol; 2016 Mar; 38(1):107-22. PubMed ID: 27049372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary and secondary glomerular diseases].
    Birck R; Banas B
    Dtsch Med Wochenschr; 2011 Apr; 136(14):703-5. PubMed ID: 21448831
    [No Abstract]   [Full Text] [Related]  

  • 3. Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis.
    Syed R; Rehman A; Valecha G; El-Sayegh S
    Biomed Res Int; 2015; 2015():402826. PubMed ID: 26688808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.
    Rovin BH; Adler SG; Barratt J; Bridoux F; Burdge KA; Chan TM; Cook HT; Fervenza FC; Gibson KL; Glassock RJ; Jayne DRW; Jha V; Liew A; Liu ZH; Mejía-Vilet JM; Nester CM; Radhakrishnan J; Rave EM; Reich HN; Ronco P; Sanders JF; Sethi S; Suzuki Y; Tang SCW; Tesar V; Vivarelli M; Wetzels JFM; Lytvyn L; Craig JC; Tunnicliffe DJ; Howell M; Tonelli MA; Cheung M; Earley A; Floege J
    Kidney Int; 2021 Oct; 100(4):753-779. PubMed ID: 34556300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardized classification and reporting of glomerulonephritis.
    Sethi S; Fervenza FC
    Nephrol Dial Transplant; 2019 Feb; 34(2):193-199. PubMed ID: 30124958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular capillary and endothelial cell injury is associated with the formation of necrotizing and crescentic lesions in crescentic glomerulonephritis.
    Fujita E; Nagahama K; Shimizu A; Aoki M; Higo S; Yasuda F; Mii A; Fukui M; Kaneko T; Tsuruoka S
    J Nippon Med Sch; 2015; 82(1):27-35. PubMed ID: 25797872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is new in therapy of glomerulonephritis in 2003/2004.
    Hruby Z
    Rocz Akad Med Bialymst; 2004; 49():166-9. PubMed ID: 15631335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary and secondary glomerular diseases].
    Birck R; Banas B; Benck U
    Dtsch Med Wochenschr; 2016 Aug; 141(16):1158-60. PubMed ID: 27509344
    [No Abstract]   [Full Text] [Related]  

  • 9. ANCA-associated pauci-immune glomerulonephritis: always pauci-immune?
    Scaglioni V; Scolnik M; Catoggio LJ; Christiansen SB; Varela CF; Greloni G; Rosa-Diez G; Soriano ER
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):55-58. PubMed ID: 28229825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced glomerular disease: immune-mediated injury.
    Hogan JJ; Markowitz GS; Radhakrishnan J
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1300-10. PubMed ID: 26092827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etiology and Outcome of Crescentic Glomerulonephritis From a Single Center in China: A 10-Year Review.
    Chen S; Tang Z; Xiang H; Li X; Chen H; Zhang H; Hu W; Zeng C; Liu Z
    Am J Kidney Dis; 2016 Mar; 67(3):376-83. PubMed ID: 26388283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic and translational concepts of immune-mediated glomerular diseases.
    Couser WG
    J Am Soc Nephrol; 2012 Mar; 23(3):381-99. PubMed ID: 22282593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of Kidney Function Among Patients With Glomerular Disease Starting Maintenance Dialysis.
    Kwong YD; Liu KD; Hsu RK; Johansen KL; McCulloch CE; Seth D; Fallahzadeh MK; Grimes BA; Ku E
    Am J Kidney Dis; 2021 Feb; 77(2):303-305. PubMed ID: 32771649
    [No Abstract]   [Full Text] [Related]  

  • 14. Crescentic Glomerulonephritis: an update on Pauci-immune and Anti-GBM diseases.
    Kambham N
    Adv Anat Pathol; 2012 Mar; 19(2):111-24. PubMed ID: 22313839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of complement in glomerulonephritis-are novel therapies ready for prime time?
    Cheung CK; Dormer JP; Barratt J
    Nephrol Dial Transplant; 2023 Jul; 38(8):1789-1797. PubMed ID: 36307926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the pathology of glomerular diseases.
    Weening JJ; Ronco P; Remuzzi G
    Contrib Nephrol; 2013; 181():12-21. PubMed ID: 23689563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic T-Cell Responses in Immune-Mediated Glomerulonephritis.
    Linke A; Tiegs G; Neumann K
    Cells; 2022 May; 11(10):. PubMed ID: 35626662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis of immune glomerulonephritis].
    Rougier JP; Ronco P
    Rev Prat; 2003 Nov; 53(18):1998-2004. PubMed ID: 15008213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
    Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
    Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research advances on targeted-Treg therapies on immune-mediated kidney diseases.
    Li Y; Liu H; Yan H; Xiong J
    Autoimmun Rev; 2023 Feb; 22(2):103257. PubMed ID: 36563769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.